Nasdaq Press Releases

Cycurion, Inc. (N A S D A Q: CYCU) $CYCU Receives High-Profile Industry Recognition, Expanding Government Contracts, and Strengthening Financial Position Highlight CYCU's Growth Trajectory

First Procedures Performed in Florida by $CDIX Demonstrate Commitment to Best-in-Class Healthcare for Underserved Traumatic Injury Populations

IQSTEL, Inc. (N A S D A Q: IQST) $IQST Reports Record Q3 2025 Results with $102.8 Million Quarterly Revenue, 42% Sequential Growth and Strengthened Balance Sheet.

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) NRXP Also Reports Its Superior Preservative-Free IV Ketamine Now Submitted for FDA Abbreviated New Drug Application

Cycurion, Inc. (N A S D A Q: CYCU) $CYCU and IQSTEL (N A S D A Q: IQST) $IQST Strengthen Alliance by Retaining $1,000,000 Worth of Cross Holdings and Distribution of $500,000 of Shares to Their Own Shareholders

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP; $750 Million Market for Suicidal Depression Market Awaits

$430 Million 2026 Revenue Forecast for $IQST, 26% Organic Growth, and $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story

$NRXP Has Manufactured Multiple Commercial Lots of NRX-100 and KETAFREE™ with a Shelf Life of Three Years.

Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) $ASTI Positioned to Serve the Rapidly Expanding $1 Trillion Global Space Economy Projected by 2040

Uni-Fuels Holdings Limited (N A S D A Q: UFG) $UFG Strengthens Global Presence in Dubai and Shanghai, Achieves ISCC Certification, and Raises Strategic Capital to Power Next-Stage Growth

Analyst D. Boral Targets NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP at $34 Per Share — Pioneering Breakthroughs in Treatment-Resistant Depression and Chronic Pain

H.C. Wainwright Initiates Coverage with $34 Price Target, Citing Paradigm Shift in Depression Treatment. NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP

Cybersecurity stocks: $cycu $goog $panw $zs $chkp $cybr $ffiv $crwd $ftnt $okta

Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) $ASTI ….Longer Space Missions for NASA and Other Agencies. Longer Space Missions for NASA and Other Agencies via Agreement with CisLunar Industries

IQSTEL, Inc. (N A S D A Q: IQST) $IQST is Featured in Litchfield Hills Research Report with $18 price target on high-margin growth strategy

Cycurion, Inc. (N A S D A Q: CYCU) $CYCU Just Completed Restructuring Resulting in a Very Attractive OS Count of 2.88 Million Supporting Continued NASDAQ Listing and Higher Access to Institutional Investors

Phinge® Corporation is continuing to gauge market interest for a potential Regulation A+ offering, referred to as "testing the waters" under SEC Rule 255.

SEGG Media, Inc. (N A S D A Q: SEGG) $SEGG Has a Two-Year Roadmap to Sustain On-Chain Yield, Accelerate Tokenization and Embed Blockchain Infrastructure

AI-Driven Cybersecurity Innovator Cycurion, Inc. (N A S D A Q: CYCU) $CYCU Strengthens Balance Sheet, Expands Federal & Fortune 500 Partnerships, and Realigns for Institutional Investment

Professor Sergio Castro Vázquez of GestiónFinIA Analyzes Historic Market Momentum as S&P 500 Reaches 6,738 and Federal Reserve Prepares Rate Decision Amid U.S.-China Trade Developments

Cycurion, Inc. (N A S D A Q: CYCU) $CYCU Receives High-Profile Industry Recognition, Expanding Government Contracts, and Strengthening Financial Position Highlight CYCU's Growth Trajectory

First Procedures Performed in Florida by $CDIX Demonstrate Commitment to Best-in-Class Healthcare for Underserved Traumatic Injury Populations

Army veteran and Assistant Plant Manager Mr. Drost alleges retaliation and exclusion, while employees rally and leadership decisions raise questions of compliance, governance, and corporate culture.

IQSTEL, Inc. (N A S D A Q: IQST) $IQST Reports Record Q3 2025 Results with $102.8 Million Quarterly Revenue, 42% Sequential Growth and Strengthened Balance Sheet.

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) NRXP Also Reports Its Superior Preservative-Free IV Ketamine Now Submitted for FDA Abbreviated New Drug Application

Cycurion, Inc. (N A S D A Q: CYCU) $CYCU and IQSTEL (N A S D A Q: IQST) $IQST Strengthen Alliance by Retaining $1,000,000 Worth of Cross Holdings and Distribution of $500,000 of Shares to Their Own Shareholders

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP; $750 Million Market for Suicidal Depression Market Awaits

$430 Million 2026 Revenue Forecast for $IQST, 26% Organic Growth, and $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story

$NRXP Has Manufactured Multiple Commercial Lots of NRX-100 and KETAFREE™ with a Shelf Life of Three Years.

Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) $ASTI Positioned to Serve the Rapidly Expanding $1 Trillion Global Space Economy Projected by 2040

Uni-Fuels Holdings Limited (N A S D A Q: UFG) $UFG Strengthens Global Presence in Dubai and Shanghai, Achieves ISCC Certification, and Raises Strategic Capital to Power Next-Stage Growth

Analyst D. Boral Targets NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP at $34 Per Share — Pioneering Breakthroughs in Treatment-Resistant Depression and Chronic Pain

H.C. Wainwright Initiates Coverage with $34 Price Target, Citing Paradigm Shift in Depression Treatment. NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP

Cybersecurity stocks: $cycu $goog $panw $zs $chkp $cybr $ffiv $crwd $ftnt $okta

Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) $ASTI ….Longer Space Missions for NASA and Other Agencies. Longer Space Missions for NASA and Other Agencies via Agreement with CisLunar Industries

IQSTEL, Inc. (N A S D A Q: IQST) $IQST is Featured in Litchfield Hills Research Report with $18 price target on high-margin growth strategy

Cycurion, Inc. (N A S D A Q: CYCU) $CYCU Just Completed Restructuring Resulting in a Very Attractive OS Count of 2.88 Million Supporting Continued NASDAQ Listing and Higher Access to Institutional Investors

Phinge® Corporation is continuing to gauge market interest for a potential Regulation A+ offering, referred to as "testing the waters" under SEC Rule 255.

SEGG Media, Inc. (N A S D A Q: SEGG) $SEGG Has a Two-Year Roadmap to Sustain On-Chain Yield, Accelerate Tokenization and Embed Blockchain Infrastructure

AI-Driven Cybersecurity Innovator Cycurion, Inc. (N A S D A Q: CYCU) $CYCU Strengthens Balance Sheet, Expands Federal & Fortune 500 Partnerships, and Realigns for Institutional Investment

Professor Sergio Castro Vázquez of GestiónFinIA Analyzes Historic Market Momentum as S&P 500 Reaches 6,738 and Federal Reserve Prepares Rate Decision Amid U.S.-China Trade Developments

Phinge® Corporation is continuing to gauge market interest for a potential Regulation A+ offering, referred to as "testing the waters" under SEC Rule 255.

Aurelion (N A S D A Q: AURE) $AURE is Providing the Public and Institutions Access to Tokenized Gold as a Safe Haven to Inflation, Currency Devaluation and Crypto Volatility

$CYCU Initiates Legal Battle Against Naked Shorting and Defamation Aligns with Explosive Growth in AI-Driven Cybersecurity Contracts and a Shareholder Dividend via $1M Equity Alliance with IQSTEL

Ascent Solar Technologies, Inc. (N A S D A Q: ASTI) $ASTI is Positioned to Serve the Rapidly Expanding $1 Trillion Global Space Economy Projected by 2040

IQSTEL, Inc. (N A S D A Q: IQST) $IQST Featured in Litchfield Hills Research Report with $18 price target on high-margin growth strategy

Phinge® Corporation is announcing its intention to gauge market interest for a potential Regulation A+ offering, referred to as "testing the waters" under SEC Rule 255.

A Game-Changing Alliance Positions IQSTEL $IQST and $CYCU at the Vanguard of AI-Powered Cybersecurity for the Global Telecom and Fintech Landscape

Stock trading platforms can innovate into the app-less world of Netverse, to bring real-time trading together with universal rewards to set themselves apart from the rest of the industry.

SEGG Media (N A S D A Q: SEGG) $SEGG Media is Growing by Multi-Million Dollar Acquisitions Plan

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Refiles Abbreviated New Drug Application; $40 Price Target in New H. C. Wainright Research Report